Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Total revenues	0	0	0	0
Operating expenses:
Research and development	486,957	516,672	1,258,549	1,535,370
General and administrative	581,520	542,697	1,948,773	1,896,230
Total operating expenses	1,068,477	1,059,369	3,207,322	3,431,600
Loss from operations	(1,068,477)	(1,059,369)	(3,207,322)	(3,431,600)
Interest (expense) / income	(378,220)	0	(920,648)	3,926
Loss before income tax benefit	(1,446,697)	(1,059,369)	(4,127,970)	(3,427,674)
Provision for income tax benefit	0	614,362	0	614,362
Net Loss	(1,446,697)	(445,007)	(4,127,970)	(2,813,312)
Other comprehensive income / (loss):
Foreign currency translation adjustment	371,275	(25,834)	356,765	(48,986)
Comprehensive loss	$ (1,075,422)	$ (470,841)	$ (3,771,205)	$ (2,862,298)
Loss per share:
Basic and diluted	$ (0.06)	$ (0.02)	$ (0.19)	$ (0.14)
Weighted average number of shares outstanding	22,922,387	20,808,050	22,068,290	20,798,013